Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Ever-Glory International Group, Inc.

EVKNASDAQ
Consumer Cyclical
Apparel - Manufacturers
$0.29
$0.00(0.00%)
U.S. Market opens in 12h 17m

Ever-Glory International Group, Inc. Fundamental Analysis

Ever-Glory International Group, Inc. (EVK) shows weak financial fundamentals with a PE ratio of -47.40, profit margin of -0.03%, and ROE of -0.07%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.47

Areas of Concern

ROE-0.07%
Operating Margin1.58%
We analyze EVK's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 18.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
18.6/100

We analyze EVK's fundamental strength across five key dimensions:

Efficiency Score

Weak

EVK struggles to generate sufficient returns from assets.

ROA > 10%
-0.03%

Valuation Score

Excellent

EVK trades at attractive valuation levels.

PE < 25
-47.40
PEG Ratio < 2
-0.47

Growth Score

Weak

EVK faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

EVK maintains a strong and stable balance sheet.

Debt/Equity < 1
0.85
Current Ratio > 1
1.26

Profitability Score

Weak

EVK struggles to sustain strong margins.

ROE > 15%
-6.68%
Net Margin ≥ 15%
-0.03%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is EVK Expensive or Cheap?

P/E Ratio

EVK trades at -47.40 times earnings. This suggests potential undervaluation.

-47.40

PEG Ratio

When adjusting for growth, EVK's PEG of -0.47 indicates potential undervaluation.

-0.47

Price to Book

The market values Ever-Glory International Group, Inc. at 0.03 times its book value. This may indicate undervaluation.

0.03

EV/EBITDA

Enterprise value stands at -5.38 times EBITDA. This is generally considered low.

-5.38

How Well Does EVK Make Money?

Net Profit Margin

For every $100 in sales, Ever-Glory International Group, Inc. keeps $-0.03 as profit after all expenses.

-0.03%

Operating Margin

Core operations generate 1.58 in profit for every $100 in revenue, before interest and taxes.

1.58%

ROE

Management delivers $-0.07 in profit for every $100 of shareholder equity.

-0.07%

ROA

Ever-Glory International Group, Inc. generates $-0.03 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.03%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-1.92 in free cash annually.

$-1.92

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-47.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.47

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.85

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.00

vs 25 benchmark

ROA

Return on assets percentage

-0.00

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How EVK Stacks Against Its Sector Peers

MetricEVK ValueSector AveragePerformance
P/E Ratio-47.4024.85 Better (Cheaper)
ROE-0.07%1165.00% Weak
Net Margin-0.03%749.00% Weak
Debt/Equity0.850.76 Neutral
Current Ratio1.269.23 Neutral
ROA-0.03%1271.00% Weak

EVK outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ever-Glory International Group, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Growth, Discretionary

EPS CAGR

N/A

Industry Style: Cyclical, Growth, Discretionary

FCF CAGR

N/A

Industry Style: Cyclical, Growth, Discretionary

Fundamental Analysis FAQ